Clinical trial
A Randomized Controlled Study of the Prevail Drug-Coated Balloon in Subjects With In-stent Restenosis and a Single Arm Prospectively Enrolled Study of the Prevail Drug-Coated Balloon for de Novo Lesions in Small Vessel Disease (Prevail Global).
NCT06535854 is registered in ClinicalTrials.gov with Medtronic Vascular as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Controlled Study of the Prevail Drug-Coated Balloon in Subjects With In-stent Restenosis and a Single Arm Prospectively Enrolled Study of the Prevail Drug-Coated Balloon for de Novo Lesions in Small Vessel Disease (Prevail Global).
- Lead sponsor
- Medtronic Vascular
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- February 24, 2025
- Completion date
- February 28, 2031
- Enrollment
- 1,205 (estimated)
- Sites
- 51
Conditions
As the registry lists them; a condition with its own page is linked.